Cambridge Nutritional Sciences plc Stock: price and insider trades · United Kingdom
No insider purchase over the last 90 days. The latest, by Carolyn Rand, was filed 19 Nov 2025.
Cambridge Nutritional Sciences plc: what insiders have been doing
Cambridge Nutritional Sciences plc is a Health Care company. Its directors and officers file their transactions with RNS (LSE). From 22 October 2025 to 22 October 2026, the disclosure feed for Cambridge Nutritional Sciences plc logged 2 filings by 2 insiders.
No insider sold shares on the market over the period. Instead, the filings list 2 purchases totalling €8,566, made by 2 insiders. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The buyers include 2 board members. Jeremy Millard filed the largest purchase, €4,540, on 19 November 2025.
Across the 832 companies tracked on its exchange, the median is 6 filings; at 2 filings, this issuer sits below that mark. Our records for Cambridge Nutritional Sciences plc go back to 2019, with 7 purchases and 1 sale on the open market in total.
In the case of 2 purchases, another manager of the company was buying within the same 30 days. Purchases made close together by different insiders form what is called a cluster. The last insider purchase was made public on 19 November 2025, 354 days ago.
Every figure here comes from the filings published by RNS (LSE) and describes the past, not future prices; it is not investment advice.
Who traded when
BuySaleSince the insiders bought
- -24.4%Entry £0.02 · Close 20 Oct 2026 £0.02
- -24.4%Entry £0.02 · Close 20 Oct 2026 £0.02
- +40.4%Entry £0.03 · Close at T+365 £0.04
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended March 2026 · cache
- 150,000 shares@ £0.023731.9% of flowLondon Stock ExchangeISIN GB00B1VCP282RNS:73b4db2a-9f62-49b1-bdb1-692e0f74b3c4-0Canonical exit: 16 Feb 2026 (T+90)
- 168,776 shares@ £0.0237100.0% of flowLondon Stock ExchangeISIN GB00B1VCP282RNS:73b4db2a-9f62-49b1-bdb1-692e0f74b3c4-1Canonical exit: 16 Feb 2026 (T+90)
- 100,000 shares@ £0.035934.2% of flowLondon Stock ExchangeISIN GB00B1VCP282RNS:5528353Canonical exit: 6 May 2025 (T+90)
- 97,500 shares@ £0.036733.8% of flowLondon Stock ExchangeISIN GB00B1VCP282RNS:5520391Canonical exit: 29 Apr 2025 (T+90)
- 296,009 shares@ £0.027100.0% of flowLondon Stock ExchangeISIN GB00B1VCP282RNS:4869332Canonical exit: 12 Nov 2023 (T+90)
- 35,721 shares@ £0.0053100.0% of flowLSEISIN GB00B1VCP282FCA-NSM:3800929Canonical exit: 1 Mar 2021 (T+90)
- 4,554 shares@ £0.11245.0% of flowLSEISIN GB00B1VCP282FCA-NSM:LSE20191216160504_14350870_20200326185105650_13901-0
- 4,554 shares@ £0.134955.0% of flowLSEISIN GB00B1VCP282FCA-NSM:LSE20191216160504_14350870_20200326185105650_13901-1Canonical exit: 15 Mar 2020 (T+90)
8 of 8 declarations
About Cambridge Nutritional Sciences plc
Cambridge Nutritional Sciences plc is a publicly traded company on the London Stock Exchange, specializing in the development of nutritional products. It focuses on research and innovation in the health and wellness sector.
